Showcasing the Best of Welsh Business

Advert

3rd April – London
European Nanomedicine Meeting 2017

SHARE
,

European Nanomedicine Meeting 2017
3-4 April 2017, London.Gala Dinner 3 April, The Crypt, St Paul’s.

The field of Nanomedicine continues to accelerate, and several trans-European research endeavours are focused on delivering benefits to patients. Nanomedicine promises to bring about a paradigm shift in the treatment and diagnosis of disease, with emerging technologies being explored across a number of diseases and indications. After a very successful edition of the European Nanomedicine Meeting in Grenoble in 2015, the British Society for Nanomedicine is proud to work with European colleagues to host ENM2017 in London.The European Nanomedicine Meeting 2017 will take place on the 3rd and 4th of April 2017 at Kings College London, UK.

The meeting will provide a forum for international exchange of research to facilitate translation and innovation in nanomedicine research and development. Leading experts and international stakeholders will have the opportunity to discuss opportunities and challenges in this exciting new field of medicine. The meeting will provide delegates with a pulse on the latest developments, as well as a systematic understanding of new nanomedicine paradigms across the development pathway.

Don’t miss this opportunity to participate in the second edition of the European Nanomedicine Meeting in London!

The Organising Committee

Here you can download the programme

ABSTRACT GUIDELINES

The maximum word count for the abstract text is 500 words (including headings and references but not title and authors).

Abstracts should be structured with the following four headings:

  • Background: a short statement of the need with clearly stated aim;
  • Methods: a concise description of the experimental methods employed;
  • Results: should include numerical data generated as part of the presented study;
  • Conclusions: a summary of major findings and implications.

Authors of accepted abstracts agree to attend the meeting and present their work as scheduled by the organisers. The Meeting will have availability for oral presentations and a large poster session.

Category of submitted abstract

For programming purposes please indicated which of the following categories best describes you abstract:

  • Fundamental Nanomedicine: work describing new technological advances
  • Preclinical Nanomedicine: work including in vitro and/or in vivo validation of performance
  • Translational Nanomedicine: work describing application and/or clinical evaluation of nanomedicine approaches

Abstract submission is open NOW

  • Abstract submission deadline: 28th January 2017
  • Notification of acceptance (including category): 15th February 2017
  • All abstracts will be scored and highest scoring abstracts will be selected for oral communication. Guidelines for poster presenters will follow.
  • Please note that the Early Bird Registration is 1st  March 2017
  • Final Registration deadline: 20th March 2017
  • Here you can download the registration form
  • Once completed please forward it to britishsocietyfornanomedicine@gmail.com

Find out more here.

SHARE

Posted by:

Life Sciences Hub Wales is the focal point for the Life Sciences sector in Wales – stimulating innovation, collaboration and investment.

The Hub is the ‘nerve centre’ for the eco-system in Wales, facilitating and encouraging innovation, aligning research with commercialisation, providing access to finance and expertise, and supporting business development in existing organisations.

Bringing together all facets of the network in Wales including academic, business, clinical, government, professional services and funding organisations, the Hub provides a commercially-driven resource for the sector.

The Hub hosts and engages organisations large and small and not only those in Life Sciences but a fully engaged network of professional services providing expertise and support to the sector.

Member organisations and partners benefit from a dedicated venue and a single access point to bespoke facilities, co-ordinated support, networking opportunities, professional advice, exclusive events, and most importantly promotional and funding opportunities.

Business and organisations working at the Hub include those operating in Pharmaceutical, Medical Technology, Biotechnology, Research & Development, Diagnostics, Clinical, Funding, Service & Supply Chain, and Business Support.

Get in touch to find out how your business or organisation can benefit from working with the Hub and discover more about our network of entrepreneurs, academics, SMEs and multinational corporations, and find out more about Wales’ impact on the global Life Sciences eco-system.

Related Articles